Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Goldman Sachs, Morgan Stanley downgrade China stocks
Goldman Sachs, Morgan Stanley downgrade China outlook
SINGAPORE (Reuters) -Hong Kong stocks are cheap but may miss out on the benefits of China's economic support, analysts at Goldman Sachs said, while Morgan Stanley warned tensions and tariffs could hurt,
Goldman Sachs sees more China tariffs in early 2025 with Trump set to return
Goldman Sachs predicts additional tariffs on China, but sees domestic challenges as the bigger issue. Read more here.
Goldman Sachs, Morgan Stanley downgrade China stocks as growth falters
Goldman Sachs and Morgan Stanley downgraded their forecasts for Hong Kong and Chinese stocks, citing economic concerns and potential political impacts. While bullish on mainland China, Goldman Sachs believes Hong Kong will see limited growth and recommends mainland investments due to lower global sensitivity.
Goldman Sachs downgrades Hong Kong stocks to underweight
Hong Kong stocks are cheap but may miss out on the benefits of China's efforts to support its economy, analysts at Goldman Sachs said, while downgrading their recommendation on the market. "Although valuations are not demanding,
Goldman Sachs Vs. Morgan Stanley: Which Big Bank Is The Better Buy?
Goldman Sachs and Morgan Stanley are two of the largest investment banks, excelling in Wealth Management, M&A, Trading, and Brokerage. Despite frequent comparisons, the banks have distinct differences in their business plans, priorities, and strategic visions.
45m
on MSN
Goldman Sachs: Trump tax cuts, deregulation will boost growth; tariffs could be a drag
Goldman Sachs economists released an analysis that projected that President-elect Trump's tax cuts and deregulation will ...
Business Insider
10h
Goldman Sachs Reaffirms Their Buy Rating on BioNTech SE (BNTX)
Goldman
Sachs
analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $137.00. The company’s shares closed last Friday at $99.72.
1d
Goldman Sachs: US To Dominate 2025 Growth With 2.5% GDP Boost, Euro Area Will Struggle
Goldman Sachs Research predicts a strong year for global economic growth in 2025, forecasting a 2.7% increase in global GDP ...
Inside Bitcoins
1d
SEC Filing Shows Goldman Sachs Holds Over $700 Million In Spot BTC ETFs
Wall Street investment banking giant Goldman Sachs holds more than $700 million in spot Bitcoin ETF (exchange-traded fund) ...
3d
Inside the Goldman Sachs marketing push that has some execs perplexed
The Wall Street giant set out to build a marketing 'army' under its first CMO. Some high-level insiders question whether it's ...
3d
Goldman Sachs Now Expects Slower Pace of Rate Cuts From BOE
Goldman Sachs said it now expects the Bank of England to take a slower approach to interest-rate cuts after the UK budget ...
cryptoglobe
2d
Goldman Sachs Increases Bitcoin ETF Exposure by 83% to Now Hold $710 Million
Wall Street giant Goldman Sachs has revealed in a new filing with the U.S .Securities and Exchange Commission that it ...
5d
How 9 newly minted Goldman Sachs partners celebrated their big day, from the 'quick little happy dance' to popping Champagne in the office
There were celebrations across Goldman Sachs last week after it promoted 95 executives to partner. Here's how nine new ...
14h
on MSN
Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs
Hedge funds ended the week as net buyers of stocks in U.S. financial and healthcare companies, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
China
Trump
Australia
United States
BlackRock
Feedback